Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Azacitidine and prophylactic donor lymphocyte infusions after hematopoietic stem cell transplantation for pediatric high-risk acute myeloid leukemia.

Autor: Huschart E; Phoenix Children's Hospital, Center for Cancer and Blood Disorders, Phoenix, Arizona, USA., Miller H; Phoenix Children's Hospital, Center for Cancer and Blood Disorders, Phoenix, Arizona, USA.; Mayo Clinic Arizona, Phoenix, Arizona, USA., Salzberg D; Phoenix Children's Hospital, Center for Cancer and Blood Disorders, Phoenix, Arizona, USA., Campbell C; Phoenix Children's Hospital, Center for Cancer and Blood Disorders, Phoenix, Arizona, USA., Beebe K; Phoenix Children's Hospital, Center for Cancer and Blood Disorders, Phoenix, Arizona, USA.; Mayo Clinic Arizona, Phoenix, Arizona, USA., Schwalbach C; Phoenix Children's Hospital, Center for Cancer and Blood Disorders, Phoenix, Arizona, USA., Magee K; Phoenix Children's Hospital, Center for Cancer and Blood Disorders, Phoenix, Arizona, USA., Adams RH; Phoenix Children's Hospital, Center for Cancer and Blood Disorders, Phoenix, Arizona, USA.; Mayo Clinic Arizona, Phoenix, Arizona, USA., Ngwube A; Phoenix Children's Hospital, Center for Cancer and Blood Disorders, Phoenix, Arizona, USA.; Mayo Clinic Arizona, Phoenix, Arizona, USA.

Publikováno v: Pediatric hematology and oncology [Pediatr Hematol Oncol] 2021 Mar; Vol. 38 (2), pp. 154-160. Date of Electronic Publication: 2020 Nov 05.